Abbott Supports Establishment of Pediatric Amino Acid Formula Emergency Assistance Fund

Originally published at Abbott ranked No. 3 on The Fair360, formerly DiversityInc Top 50 Companies for Diversity list in 2022.


We know that the shortage of amino acid-based formulas has been challenging and, in some cases, has required children to seek medical treatment.

Patient Advocate Foundation (PAF) has established a Pediatric Amino Acid Formula Emergency Assistance Fund through the support of Abbott. This fund is for patients on amino acid-based formulas who have required hospitalizations or emergency room visits as a result of the amino acid-based formula shortage. It will help them with medical and living expenses incurred from the shortage. The fund is accessible to all families who meet the eligibility criteria, regardless of income, on a first-come, first-served basis, to the extent funding is available.

Families can complete their application here or call (855) 949-3915 to begin the application process. They will need to answer a few questions to determine eligibility, including providing the name of their child’s healthcare professional (HCP). PAF will verify details, including contacting designated HCPs, and approve grants to qualifying patients. Grants will be approved in the amount of $4,500 per patient.

Additionally, as previously communicated, Abbott has quantities of its amino acid-based formula, EleCare, available to support patients. This product is being released to consumers in need, free of charge, in coordination with healthcare professionals. Parents or caregivers in need should contact their healthcare professional or contact Abbott at (800) 881-0876 for additional information.